Heart RateREFLECTNCT06842641
Assessing the Effect of Cool Roofs on Health Using Smartwatches in Ouagadougou, Burkina Faso
A study testing Cool roof in people with Heart Rate and All-day Steps, run by Institut Supérieur des Sciences de la Population at 1 site in Burkina Faso.
Trial summary
Ambient air temperatures in Africa, have broken record highs in 2024. Solutions are needed to build heat resilience in communities and adapt to increasing heat from climate change. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Heart Rate, All-day Steps, Distance Walked
- What is being tested?
- Cool roof
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 200 participants
- Where
- 1 siteBurkina Faso
- Study dates
- 20 Mar 2025to 20 Mar 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- • Permanent household resident
Who cannot join
- • Roof damage, inaccessible or instability of roof adversely affecting cool roof coating application.
- Participant unable to provide written/verbal informed consent. Participants will be excluded if they are not willing or able to wear a smartwatch.
- One participant per household.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Burkina Faso1 site
Ouagadougou Health and Demographic Surveillance System
Ouagadougou
Yacouba Compaoré, Doctor of Philosophy (Ph.D), +226 70562664, compaoreyacouba@gmail.com
Idrissa Ouili, Doctor of Philosophy (Ph.D), +226 60158080, ouilidris@gmail.com
About this study
Official title: A Cluster Randomized Controlled Trial (cRCT) Evaluating the Effects of Cool Roofs on Health Outcomes Using Smartwatches in Ouagadougou, Burkina Faso
Ambient air temperatures in Africa, have broken record highs in 2024. Solutions are needed to build heat resilience in communities and adapt to increasing heat from climate change. Sunlight-reflecting cool roof coatings may passively reduce indoor temperatures and energy use to protect home occupants from extreme heat. Occupants living in poor housing conditions- for example in informal settlements, slums, and low-socioeconomic households - are susceptible to increased heat exposure.
Heat exposure can instigate and worsen numerous physical, mental and social health conditions. The worst adverse health effects are experienced in communities that are least able to adapt to heat exposure. By reducing indoor temperatures, cool roof application may improve heart health, sleep and physical activity in household occupants.
The long-term research goal is to identify viable passive housing adaptation technologies with proven health benefits to reduce the burden of heat stress in communities affected by heat. To meet this goal, the investigators will use smartwatches to measure the effects cool roof application on heart health, sleep and physical activity in Ouagadougou, Burkina Faso.
Read the detailed description
Increasing heat exposure from climate change is causing and exacerbating heat-related illnesses in millions worldwide - particularly in low resource settings. June 2024 was the 13th consecutive hottest month on record globally - shattering previous records. Heat exposure can instigate and worsen numerous health conditions. Adaptation is essential for protecting people from increasing heat exposure. The built environment, especially homes, are ideal for deploying interventions to reduce heat exposure and accelerate adaptation efforts. However, evidence is currently lacking on a global scale - generated through empirical studies - guiding the uptake of interventions to reduce indoor heat stress in low resource settings.
Sunlight-reflecting cool roof coatings passively reduce indoor temperatures and lower energy use, offering protection to home occupants from extreme heat. Continuous monitoring of health and wellbeing using smartwatches can provide insight into important parameters such as heart rate, sleep and physical activity - which are all affected by heat. Using smartwatches, the investigators will also continuously measure health and wellbeing outcomes during the day and night. The investigators will conduct a study to investigate the effects of cool-roof use on heart rate, sleep and physical activity in Ouagadougou, Burkina Faso (sub-Saharan Africa, where people experience a triple burden from heat exposure, chronic health issues and vulnerable housing conditions (slums, informal settlements and low socioeconomic housing).
This trial will quantify whether cool roofs are an effective passive home cooling intervention with beneficial health effects for vulnerable populations in Burkina Faso. Findings will inform global policy responses on scaling cool roof implementation to protect people from increasing heat exposure driven by climate change.
- Conditions
- Heart Rate, All-day Steps, Distance Walked, Active Minutes, Moderate-intensity Activity Minutes, Sleep Quantity
- Being tested
- Cool roof
- Keywords
- Hot Temperature, Humidity, Housing, Wearable, Smartwatch, Heart rate, Cardiovascular, Physical activity, Sleep, Cool roof
- Medical subject headings
- Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Cool roofOther
Cool roofs are a sunlight reflecting roof coating that can reduce indoor temperature. Cool roofs have high solar reflectance (reflecting the ultraviolet and visible wavelengths of sunlight, reducing heat transfer to the surface of a roof) and high thermal emittance (radiating absorbed solar energy
| Study group | Role | What they receive |
|---|---|---|
| Intervention | Experimental | Households will receive sunlight reflecting 'cool roof' coating on their roofs. Receives: Other: Cool roof |
| Control | No intervention | No cool roof application. Households will keep their original roofing for the duration of the trial. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Heart rate
Heart rate in beats per minute measured at 15-second intervals using Garmin Vivosmart 5 devices. Measurements will be taken continuously for 12 months. Participants will be asked to wear their smartwatch for at least two weeks every month.
Measured: The outcome will be measured at 15-second intervals continuously throughout each 12-month period, with participants wearing the device for at least two weeks per month to capture consistent data points.
Secondary outcomes (9)
All-day steps
The number of steps measured daily using Garmin Vivosmart 5 devices.
Measured: Measurements will be taken continuously for 12 months. Participants will be asked to wear their smartwatch for at least two weeks every month.
Distance walked
The total distance walked daily using Garmin Vivosmart 5 devices
Measured: Measurements will be taken continuously for 12 months. Participants will be asked to wear their smartwatch for at least two weeks every month.
Active minutes
The total number of minutes of active exercise daily using Garmin Vivosmart 5 devices.
Measured: Measurements will be taken continuously for 12 months. Participants will be asked to wear their smartwatch for at least two weeks every month.
Moderate-intensity activity minutes
The total number of minutes of moderate-intensity activity daily using Garmin Vivosmart 5 devices.
Measured: Measurements will be taken continuously for 12 months. Participants will be asked to wear their smartwatch for at least two weeks every month.
Vigorous-intensity activity duration
The total number of minutes of vigorous-intensity activity daily using Garmin Vivosmart 5 devices.
Measured: Measurements will be taken continuously for 12 months. Participants will be asked to wear their smartwatch for at least two weeks every month.
Sleep quantity
The number of hours spent asleep each night using Garmin Vivosmart 5 devices.
Measured: Measurements will be taken continuously for 12 months. Participants will be asked to wear their smartwatch for at least two weeks every month.
Time in sleep stages
The number of hours spent in sleep stages each night using Garmin Vivosmart 5 devices.
Measured: Measurements will be taken continuously for 12 months. Participants will be asked to wear their smartwatch for at least two weeks every month.
Awake duration
The number of hours spent awake during sleep time each night using Garmin Vivosmart 5 devices.
Measured: Measurements will be taken continuously for 12 months. Participants will be asked to wear their smartwatch for at least two weeks every month.
Sleep score
The Garmin sleep score (0-100) each night using Garmin Vivosmart 5 devices.
Measured: Measurements will be taken continuously for 12 months. Participants will be asked to wear their smartwatch for at least two weeks every month.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Feb 2025
- Study start20 Mar 2025 (estimated)
- Primary completion15 Mar 2026 (estimated)
- Study completion20 Mar 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Heart RateStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Investigator, Outcomes assessor
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Institut Supérieur des Sciences de la Population
- Sponsor type
- University, hospital or other
- Collaborators
- University of Auckland, New Zealand, Heidelberg University, London School of Hygiene and Tropical Medicine, Rutgers University, Boston University, Secretaría de Educación Pública, México, University of Ouagadougou, Burkina Faso, Indian Institute of Public Health, India, The Tindall Foundation, Habitat for Humanity, Pacific Community, Labfront, Cognifit, Resene, SOPREMA, EPS, Sika
- Responsible party
- Sponsor
- Investigators
- Aditi Bunker, Doctor of Phylosophy (Ph.D), Principal investigator, Heidelberg University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06842641
- Sponsor's protocol ID
- 3728163
- Other IDs
- 226745/Z/22/Z
- Acronym
- REFLECT
- Status last verified
- Feb 2025
- First submitted
- 18 Feb 2025
- Last updated
- 24 Feb 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Data that can be shared unconditionally underpinning the published research articles will be made available to other researchers at the time of publication, and data will be linked via the article DOI. Data that cannot be unconditionally shared upon publication owing to confidentiality or data protection requirements will be identified as such and a contact email will be provided in relevant publications for data access enquiries by other researchers. Individual names of study participants and identifying factors will be removed prior to data sharing. It is expected that demographic data of people at the study sites (family size and composition, basic socioeconomic indicators) may contain personally identifiable information and location data. All such data will be removed prior to storage on online data repositories and therefore will be available to be publicly shared at the time of publication of manuscripts.
Study at a glance
From the registry record, last updated by the sponsor on 24 Feb 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Cluster Randomized Controlled Trial (cRCT) Evaluating the Effects of Cool Roofs on Health Outcomes Using Smartwatches in Ouagadougou, Burkina Faso
- ClinicalTrials.gov ID
- NCT06842641
- Acronym / sponsor ID
- REFLECT / 3728163
- Conditions
- Heart Rate, All-day Steps, Distance Walked, Active Minutes, Moderate-intensity Activity Minutes, Sleep Quantity
- Keywords
- Hot Temperature, Humidity, Housing, Wearable, Smartwatch, Heart rate, Cardiovascular, Physical activity
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- Institut Supérieur des Sciences de la PopulationUniversity, hospital or other
- Collaborators
- University of Auckland, New Zealand, Heidelberg University, London School of Hygiene and Tropical Medicine, Rutgers University, Boston University, Secretaría de Educación Pública, México, University of Ouagadougou, Burkina Faso, Indian Institute of Public Health, India, The Tindall Foundation, Habitat for Humanity, Pacific Community, Labfront, Cognifit, Resene, SOPREMA, EPS, Sika
- Study start
- 20 Mar 2025 (estimated)
- Primary completion
- 15 Mar 2026 (estimated)
- Study completion
- 20 Mar 2026 (estimated)
- First posted
- 24 Feb 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Ambient air temperatures in Africa, have broken record highs in 2024. Solutions are needed to build heat resilience in communities and adapt to increasing heat from climate change. Sunlight-reflecting cool roof coatings may passively reduce indoor temperatures and energy use to protect home occupants from extreme heat. Occupants living in poor housing conditions- for example in informal settlements, slums, and low-socioeconomic households - are susceptible to increased heat exposure.
Heat exposure can instigate and worsen numerous physical, mental and social health conditions. The worst adverse health effects are experienced in communities that are least able to adapt to heat exposure. By reducing indoor temperatures, cool roof application may improve heart health, sleep and physical activity in household occupants.
The long-term research goal is to identify viable passive housing adaptation technologies with proven health benefits to reduce the burden of heat stress in communities affected by heat. To meet this goal, the investigators will use smartwatches to measure the effects cool roof application on heart health, sleep and physical activity in Ouagadougou, Burkina Faso.
Detailed description
Increasing heat exposure from climate change is causing and exacerbating heat-related illnesses in millions worldwide - particularly in low resource settings. June 2024 was the 13th consecutive hottest month on record globally - shattering previous records. Heat exposure can instigate and worsen numerous health conditions. Adaptation is essential for protecting people from increasing heat exposure. The built environment, especially homes, are ideal for deploying interventions to reduce heat exposure and accelerate adaptation efforts. However, evidence is currently lacking on a global scale - generated through empirical studies - guiding the uptake of interventions to reduce indoor heat stress in low resource settings.
Sunlight-reflecting cool roof coatings passively reduce indoor temperatures and lower energy use, offering protection to home occupants from extreme heat. Continuous monitoring of health and wellbeing using smartwatches can provide insight into important parameters such as heart rate, sleep and physical activity - which are all affected by heat. Using smartwatches, the investigators will also continuously measure health and wellbeing outcomes during the day and night. The investigators will conduct a study to investigate the effects of cool-roof use on heart rate, sleep and physical activity in Ouagadougou, Burkina Faso (sub-Saharan Africa, where people experience a triple burden from heat exposure, chronic health issues and vulnerable housing conditions (slums, informal settlements and low socioeconomic housing).
This trial will quantify whether cool roofs are an effective passive home cooling intervention with beneficial health effects for vulnerable populations in Burkina Faso. Findings will inform global policy responses on scaling cool roof implementation to protect people from increasing heat exposure driven by climate change.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intervention | Experimental | Other: Cool roofHouseholds will receive sunlight reflecting 'cool roof' coating on their roofs. |
| Control | No intervention | –No cool roof application. Households will keep their original roofing for the duration of the trial. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- • Permanent household resident
Key exclusion criteria (3 listed)
- • Roof damage, inaccessible or instability of roof adversely affecting cool roof coating application.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Cool roofCool roofs are a sunlight reflecting roof coating that can reduce indoor temperature. Cool roofs have high solar reflectance (reflecting the ultraviolet and visible wavelengths of sunlight, reducing heat transfer to the surface of a roof) and high thermal emittance (radiating absorbed solar energy | Other | Intervention |
Primary outcome
Heart rate
Time frame: The outcome will be measured at 15-second intervals continuously throughout each 12-month period, with participants wearing the device for at least two weeks per month to capture consistent data points.
Heart rate in beats per minute measured at 15-second intervals using Garmin Vivosmart 5 devices. Measurements will be taken continuously for 12 months. Participants will be asked to wear their smartwatch for at least two weeks every month.
9 secondary outcomes
All-day steps
Time frame: Measurements will be taken continuously for 12 months. Participants will be asked to wear their smartwatch for at least two weeks every month.
Distance walked
Time frame: Measurements will be taken continuously for 12 months. Participants will be asked to wear their smartwatch for at least two weeks every month.
Active minutes
Time frame: Measurements will be taken continuously for 12 months. Participants will be asked to wear their smartwatch for at least two weeks every month.
Moderate-intensity activity minutes
Time frame: Measurements will be taken continuously for 12 months. Participants will be asked to wear their smartwatch for at least two weeks every month.
Vigorous-intensity activity duration
Time frame: Measurements will be taken continuously for 12 months. Participants will be asked to wear their smartwatch for at least two weeks every month.
Sleep quantity
Time frame: Measurements will be taken continuously for 12 months. Participants will be asked to wear their smartwatch for at least two weeks every month.
Time in sleep stages
Time frame: Measurements will be taken continuously for 12 months. Participants will be asked to wear their smartwatch for at least two weeks every month.
Awake duration
Time frame: Measurements will be taken continuously for 12 months. Participants will be asked to wear their smartwatch for at least two weeks every month.
Sleep score
Time frame: Measurements will be taken continuously for 12 months. Participants will be asked to wear their smartwatch for at least two weeks every month.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Feb 2025.
- Individual participant dataSharing planned: Yes. Data that can be shared unconditionally underpinning the published research articles will be made available to other researchers at the time of publication, and data will be linked via the article DOI. Data that cannot be unconditionally shared upon publication owing to confidentiality or data protection requirements will be identified as such and a contact email will be provided in relevant publications for data access enquiries by other researchers. Individual names of study participants and identifying factors will be removed prior to data sharing. It is expected that demographic data of people at the study sites (family size and composition, basic socioeconomic indicators) may contain personally identifiable information and location data. All such data will be removed prior to storage on online data repositories and therefore will be available to be publicly shared at the time of publication of manuscripts.
Related trials for Heart Rate
Not yet recruiting
Smartphone Camera Measurement of Breathing-Related Heart Rate Variability Compared With ECG in Healthy Adults
Respiratory Sinus Arrhythmia, Heart Rate Variability
Recruiting
The Effect of Water Temperature on Heart Rate Variability and Cognition
Mental Acuity
Recruiting
WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
Acute Hypoxic Respiratory Failure, Acute Respiratory Distress Syndrome (ARDS)
Active, not recruiting
Effects of Individualized Preferred and Higher Treadmill Walking Speeds Followed by Cognitive Training on Heart Rate Variability, Gait Performance, and Motor-Cognitive Function in Older Adults With Type 2 Diabetes: A Randomized Controlled Trial With 4-Week Retention Follow-up
Diabetes Mellitus, Type 2
Not yet recruiting
Music Listening for Chronic Pain in Adults With Early-Stage Dementia
Chronic Pain, Alzheimer Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Aditi Bunker, Doctor of Phylosophy (Ph.D) principal investigator
Heidelberg University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Cool roof in people with Heart Rate and All-day Steps, run by Institut Supérieur des Sciences de la Population at 1 site in Burkina Faso.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 24 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Burkina Faso. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Aditi Bunker, Doctor of Philosophy (Ph.D) (+49 6221 565344, aditi.bunker@uni-heidelberg.de), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Heart rate (time frame: The outcome will be measured at 15-second intervals continuously throughout each 12-month period, with participants wearing the device for at least two weeks per month to capture consistent data points.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Feb 2025.